CEACAM5 and adenocarcinoma: Previous studies [10,11,12] revealed that pathology-adenocarcinoma/adenosquamous cell carcinoma and high tumor marker CEA influence the clinical outcome in patients receiving radiation due to the radioresistant nature of tumors.